Company intelligence / Profile preview

BIO-IB

New York, NY, USA

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Bio-IB is a boutique investment bank and strategic advisory firm dedicated exclusively to the life sciences, biotechnology, and healthcare sectors. The firm provides a range of financial services, including mergers and acquisitions (M&A) advisory, global licensing, and private placements of equity and debt. Bio-IB leverages its deep scientific and clinical expertise to assist emerging and mid-sized healthcare companies in navigating complex transactions and strategic partnerships. Headquartered in New York, the firm serves a global clientele, bridging the gap between innovative science and capital markets. Its team typically consists of professionals with dual backgrounds in science and finance, allowing for a highly technical approach to valuation and deal-making.

Industry: Investors

Beyond the preview

Go deeper on BIO-IB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIO-IB.

Explore the full profile